A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors.
about
The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and ChangesExome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure.Thymic Epithelial Tumors phenotype relies on miR-145-5p epigenetic regulationCharacterization of genetic aberrations in a single case of metastatic thymic adenocarcinoma.Mutations of epigenetic regulatory genes are common in thymic carcinomasGenome-wide targeting of the epigenetic regulatory protein CTCF to gene promoters by the transcription factor TFII-I.Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial.Novel Treatments for Thymoma and Thymic Carcinoma.Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors.Cancer genomics: why rare is valuable.State of the art: diagnostic tools and innovative therapies for treatment of advanced thymoma and thymic carcinoma.Pathophysiology of TFII-I: Old Guard Wearing New Hats.An efficient method to enrich for knock-out and knock-in cellular clones using the CRISPR/Cas9 system.PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors.Vascular architecture as a diagnostic marker for differentiation of World Health Organization thymoma subtypes and thymic carcinoma.Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic TargetsElevated CRP levels predict poor outcome and tumor recurrence in patients with thymic epithelial tumors: A pro- and retrospective analysis.Rare frequency of gene variation and survival analysis in thymic epithelial tumors.Increased cFLIP expression in thymic epithelial tumors blocks autophagy via NF-κB signalling.AB thymoma with atypical type A component with delayed multiple lung and brain metastases.Bioimpedimetric analysis in conjunction with growth dynamics to differentiate aggressiveness of cancer cells.CASTLE tumor of the parotid: First documented case, literature review, and genetic analysis of the cancer.Novel Agents in the Treatment of Thymic Malignancies.Metastatic type A thymoma: morphological and genetic correlation.A germline mutation in PBRM1 predisposes to renal cell carcinoma.Genomic Analysis of Thymic Epithelial Tumors Identifies Novel Subtypes Associated with Distinct Clinical Features.The Integrated Genomic Landscape of Thymic Epithelial Tumors.[Thymomas].The genomic and epigenomic landscape in thymic carcinomaWilliams-Beuren Syndrome as a Potential Risk Factor for Burkitt Lymphoma
P2860
Q28087370-C3DA166C-FBAE-4587-89C2-C950C23E20B8Q30388270-2BEDDCE2-9200-4638-9C98-1D7AAE99FF44Q33655180-5ED8405E-2479-42B7-8AAA-31794A59E499Q33691435-19DFDD1E-FC38-4EC2-AF97-6E2F319F982BQ34648225-F85CB846-6509-4C77-A462-AEE7CFC093A2Q35129119-02C1D997-980E-4634-B9D4-534C7112DFF9Q35462240-8682E416-ECB0-4756-8734-CA4D384E301DQ36328718-D6C590B6-8806-43E8-9F4F-7FC30152FED1Q38269843-9829FB1F-E9EE-45A5-8C42-B4521D6AD682Q38353573-F37D9CE1-964B-441F-874C-26239B452ED5Q38670220-EE1D547E-0364-4D7F-B931-B8371300210AQ38688830-487CE2A9-4AA8-4415-AF4A-F4E7EBA70831Q38707002-E031BDA0-8869-44CD-AB8F-420CC013AE23Q38775158-4176EE4F-B30F-4D15-8135-1E4CED909117Q39239578-3D43C295-04BA-4F74-8477-DB6EAC25EB6BQ41021890-CEE9F60A-87BC-4616-BD75-BAACBE8849E8Q41470915-90603504-A831-4762-8608-4F2D55CDA296Q41518202-B13AD94A-1D4C-43D9-8617-75B25694CA71Q45491251-BCC9FEEC-8E1F-4514-8D6A-3000071ED080Q47139245-3D6C1F2F-9AC6-40E7-AE43-CCFFF3E3E9A6Q48042869-07840DEE-10A6-4F78-8A1E-87EFFDC26CADQ48334446-646401F9-A7AE-4A81-AF2C-4D7387E39D4AQ48696917-34FD1943-B9E3-4C19-9CA1-B5DF15747D48Q48745100-246DA966-E3B4-470D-8F41-C9D3C92A99F7Q49092051-4F375482-8075-477F-AA19-EE69CAA16C61Q49643762-0394EFD4-7387-4719-9425-9DAC344B7DDCQ50040409-F8A9E257-B9B9-450E-8CC0-418548BBCF65Q52955529-958C8827-DD44-4FD1-A6D8-CBEF984A629AQ57700809-793351DB-C259-4E82-8D23-C4893823FB97Q58764827-E4A56046-AE2E-47FE-B844-E2138E74B8BD
P2860
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
A specific missense mutation i ...... y in thymic epithelial tumors.
@en
A specific missense mutation i ...... y in thymic epithelial tumors.
@nl
type
label
A specific missense mutation i ...... y in thymic epithelial tumors.
@en
A specific missense mutation i ...... y in thymic epithelial tumors.
@nl
prefLabel
A specific missense mutation i ...... y in thymic epithelial tumors.
@en
A specific missense mutation i ...... y in thymic epithelial tumors.
@nl
P2093
P2860
P50
P356
P1433
P1476
A specific missense mutation i ...... y in thymic epithelial tumors.
@en
P2093
Christopher Lau
Donna Voeller
Federico Rea
Fiorella Calabrese
In-Kyu Kim
Jaime Rodriguez-Canales
Kang-Seo Park
Keith J Killian
Marbin Pineda
P2860
P2888
P304
P356
10.1038/NG.3016
P407
P577
2014-06-29T00:00:00Z